Identification of trichostatin A as a novel transcriptional up-regulator of scavenger receptor BI both in HepG2 and RAW 264.7 cells

Atherosclerosis

Volumn 204, Issue 1, 2009, Pages 127-135

  Bao, Yi ^a   Yang, Yuan ^a   Wang, Li ^a   Gao, Lei ^a   Jiang, Wei ^a   Wang, Lifei ^a   Si, Shuyi ^a   Hong, Bin ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Reverse cholesterol transport (RCT); Scavenger receptor class B type I (SR BI CLA 1); Transcriptional up regulator; Trichostatin A (TSA)

Indexed keywords

ABC TRANSPORTER A1; MESSENGER RNA; SCAVENGER RECEPTOR A; SCAVENGER RECEPTOR BI; TRICHOSTATIN A;

ANIMAL CELL; ARTICLE; ASSAY; CHOLESTEROL TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG MECHANISM; GEL MOBILITY SHIFT ASSAY; GENE DELETION; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; UPREGULATION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; LIVER NEOPLASMS; MACROPHAGES; MICE; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS A; SCAVENGER RECEPTORS, CLASS B; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; UP-REGULATION;

EID: 67349261980     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.08.041     Document Type: Article

References (46)

1. Zaman A.G., Helft G., Worthley S.G., and Badimon J.J. The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis 149 (2000) 251-266
2. Lewis G.F., and Rader D.J. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96 (2005) 1221-1232
3. Acton S., Rigotti A., Landschulz K.T., et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271 (1996) 518-520
4. Cao G., Garcia C.K., Wyne K.L., et al. Structure and localization of the human gene encoding SR-BI/CLA-1. Evidence for transcriptional control by steroidogenic factor 1. J Biol Chem 272 (1997) 33068-33076
5. Ji Y., Wang N., Ramakrishnan R., et al. Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J Biol Chem 274 (1999) 33398-33402
6. Ji Y., Jian B., Wang N., et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 272 (1997) 20982-20985
7. Zhang W., Yancey P.G., Su Y.R., et al. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 108 (2003) 2258-2263
8. Covey S.D., Krieger M., Wang W., Penman M., and Trigatti B.L. Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells. Arterioscler Thromb Vasc Biol 23 (2003) 1589-1594
9. Zhang Y., Da Jr. S., Reilly M., et al. Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J Clin Invest 115 (2005) 2870-2874
10. Kozarsky K.F., Donahee M.H., Rigotti A., et al. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 387 (1997) 414-417
11. Wang N., Arai T., Ji Y., Rinninger F., and Tall A.R. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. J Biol Chem 273 (1998) 32920-32926
12. Rigotti A., Trigatti B.L., Penman M., et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA 94 (1997) 12610-12615
13. Acton S.L., Kozarsky K.F., and Rigotti A. The HDL receptor SR-BI: a new therapeutic target for atherosclerosis?. Mol Med Today 5 (1999) 518-524
14. Rader D.J. Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest 116 (2006) 3090-3100
15. Yang Y., Zhang Z., Jiang W., et al. Identification of novel human high-density lipoprotein receptor Up-regulators using a cell-based high-throughput screening assay. J Biomol Screen 12 (2007) 211-219
16. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 (2001) e45
17. Baranova I., Vishnyakova T., Bocharov A., et al. Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells. Infect Immun 70 (2002) 2995-3003
18. Tsuji N., Kobayashi M., Nagashima K., Wakisaka Y., and Koizumi K. A new antifungal antibiotic, trichostatin. J Antibiot (Tokyo) 29 (1976) 1-6
19. Yoshida M., Kijima M., Akita M., and Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265 (1990) 17174-17179
20. Malerod L., Juvet L.K., Hanssen-Bauer A., Eskild W., and Berg T. Oxysterol-activated LXRalpha/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes. Biochem Biophys Res Commun 299 (2002) 916-923
21. Malerod L., Sporstol M., Juvet L.K., et al. Hepatic scavenger receptor class B, type I is stimulated by peroxisome proliferator-activated receptor gamma and hepatocyte nuclear factor 4alpha. Biochem Biophys Res Commun 305 (2003) 557-565
22. Treguier M., Doucet C., Moreau M., et al. Transcription factor sterol regulatory element binding protein 2 regulates scavenger receptor Cla-1 gene expression. Arterioscler Thromb Vasc Biol 24 (2004) 2358-2364
23. Schoonjans K., Annicotte J.S., Huby T., et al. Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I. EMBO Rep 3 (2002) 1181-1187
24. Hsu L.A., Ko Y.L., Wu S., et al. Association between a novel 11-base pair deletion mutation in the promoter region of the scavenger receptor class B type I gene and plasma HDL cholesterol levels in Taiwanese Chinese. Arterioscler Thromb Vasc Biol 23 (2003) 1869-1874
25. Rodriguez-Esparragon F., Rodriguez-Perez J.C., Hernandez-Trujillo Y., et al. Allelic variants of the human scavenger receptor class B type 1 and paraoxonase 1 on coronary heart disease: genotype-phenotype correlations. Arterioscler Thromb Vasc Biol 25 (2005) 854-860
26. de Ruijter A.J., van Gennip A.H., Caron H.N., Kemp S., and van Kuilenburg A.B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370 (2003) 737-749
27. Vigushin D.M., and Coombes R.C. Targeted histone deacetylase inhibition for cancer therapy. Curr Cancer Drug Targets 4 (2004) 205-218
28. Choi J.H., Oh S.W., Kang M.S., et al. Trichostatin A attenuates airway inflammation in mouse asthma model. Clin Exp Allergy 35 (2005) 89-96
29. Camelo S., Iglesias A.H., Hwang D., et al. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol 164 (2005) 10-21
30. Chung Y.L., Lee M.Y., Wang A.J., and Yao L.F. A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. Mol Ther 8 (2003) 707-717
31. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 340 (1999) 115-126
32. Doris B., Parks J., Rankin C., et al. Histone deacetylase inhibitors may prevent atherosclerosis while treating lupus. Arthritis Rheum 52 (2005) S698 Abstract
33. Nieland T.J., Penman M., Dori L., Krieger M., and Kirchhausen T. Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI. Proc Natl Acad Sci USA 99 (2002) 15422-15427
34. Glaser K.B., Staver M.J., Waring J.F., et al. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Mol Cancer Ther 2 (2003) 151-163
35. Kiernan R., Bres V., Ng R.W., et al. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem 278 (2003) 2758-2766
36. Cuchel M., and Rader D.J. Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?. Circulation 113 (2006) 2548-2555
37. de Winther M.P., van Dijk K.W., Havekes L.M., and Hofker M.H. Macrophage scavenger receptor class A: a multifunctional receptor in atherosclerosis. Arterioscler Thromb Vasc Biol 20 (2000) 290-297
38. Laribee R.N., and Klemsz M.J. Loss of PU. 1 expression following inhibition of histone deacetylases. J Immunol 167 (2001) 5160-5166
39. Choi J.H., Nam K.H., Kim J., et al. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 25 (2005) 2404-2409
40. Natesampillai S., Fernandez-Zapico M.E., Urrutia R., and Veldhuis J.D. A novel functional interaction between the Sp1-like protein KLF13 and SREBP-Sp1 activation complex underlies regulation of low density lipoprotein receptor promoter function. J Biol Chem 281 (2006) 3040-3047
41. Schnur N., Seuter S., Katryniok C., Radmark O., and Steinhilber D. The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes. Biochim Biophys Acta 1771 (2007) 1271-1282
42. Zhao S., Venkatasubbarao K., Li S., and Freeman J.W. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells. Cancer Res 63 (2003) 2624-2630
43. Yamaguchi K., Lantowski A., Dannenberg A.J., and Subbaramaiah K. Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2. J Biol Chem 280 (2005) 32569-32577
44. Langmann T., Porsch-Ozcurumez M., Heimerl S., et al. Identification of sterol-independent regulatory elements in the human ATP-binding cassette transporter A1 promoter: role of Sp1/3, E-box binding factors, and an oncostatin M-responsive element. J Biol Chem 277 (2002) 14443-14450
45. Ruan X.Z., Varghese Z., Powis S.H., and Moorhead J.F. Human mesangial cells express inducible macrophage scavenger receptor. Kidney Int 56 (1999) 440-451
46. Mizutani T., Yamada K., Minegishi T., and Miyamoto K. Transcriptional regulation of rat scavenger receptor class B type I gene. J Biol Chem 275 (2000) 22512-22519